摘要:
A composite woven fabric (100, 200, 300, 420) for a low profile implantable medical device (400) having a plurality of textile strands of a first material (110, 210, 310, 420) aligned in a first direction interlaced with a plurality of textile strands of a second material (120, 220, 320, 422). The textile strands have a size between about 10 denier to about 20 denier. The first material (110, 210, 310, 420) has at least one characteristic different from the second material (120, 220, 320, 422) and reacts more favorably with blood when placed within an artery.
摘要:
A woven fabric (300, 400, 500, 620) for a low profile implantable medical device (600) includes a plurality of textile strands of a composite yarn (100, 200, 310, 410, 510, 622) aligned in a first direction interlaced with a plurality of textile strands of the composite yarn (100, 200, 320, 420, 520, 624) aligned in a second direction. The composite yarn includes a combination of a first material (112, 212) and a second material (114, 214). The textile strands have a size between about 10 denier to about 20 denier. The first material (112, 212) has at least one characteristic different from the second material (114, 214) and reacts favorably with blood when placed within an artery.
摘要:
A composite wire product includes a biodegradable parent material which forms the bulk of the cross-sectional area of the wire, and a central fiber or filament of a slower-degrading or non-biodegradable material runs throughout the length of the wire. This central filament promotes the mechanical integrity of an intraluminal appliance or other medical device made from the wire product throughout the biodegradation process by preventing non-absorbed parent material from dislodging from the central filament. Thus, the present wire design enables the creation of medical devices that are designed to improve in flexibility toward a more natural state over the course of healing, while also controlling for the possibility of non-uniform in vivo erosion.
摘要:
In some aspects, a graft device can include a biodegradable inner layer, an outer layer, a first end portion, a second end portion, and a lumen therebetween. The biodegradable inner layer typically includes an inner surface and an outer surface. The outer layer typically includes a fiber matrix surrounding the outer surface of the inner layer. The graft device can include a reinforced end portion. At least 10% or at least 50% of the graft device can remain after 90 days of implantation. In some cases, at least 10% or at least 50% of the graft device can remain after 180 days of implantation. The graft device can include a kink-resisting element. The graft device can include at least one layer with a dynamic compliance less than or equal to at least one of: 20%/100 mmHg or 5%/100 mmHg.
摘要:
An endoluminal filter can have a support structure or frame made of a biodegradable material such as biodegradable metal or biodegradable polymer. The endoluminal filter can further have a plurality of anchor elements made of biodegradable material, which are removed by biodegradation when the endoluminal filter is at least partially incorporated into a wall of a blood vessel. Additionally, the endoluminal filter can have a material capture structure made of a biodegradable material,and it can be attached to the support structure. The endoluminal filters can be configured to allow selective biodegradation of its components.
摘要:
Disclosed is a hybrid surgical mesh that is partially absorbable or biodegradable. The hybrid surgical mesh described herein generally comprises a central absorbable or biodegradable portion surrounded on at least its sides by a non-absorbable portion which forms a support structure for supporting a prolapsed region. While the absorbable or biodegradable portion provides support to the prolapsed region immediately following the surgical procedure to correct such prolapse, over time the central absorbable or biodegradable portion dissolves so as to leave only the non-absorbable interrupted hammock-like support structure. Such configuration provides the initial structural support required after the surgical procedure necessary to ensure healing and strengthening of the prolapsed region, while significantly reducing the risk of healing abnormalities or complications resulting in the central portion of the graft.
摘要:
A vascular filter (20) includes filtration struts (26) formed between a hub (24) and a supporting stent structure including stent struts (22). The hub (24) and the filtration basket are formed from a material that is more biodegradable that the material from which the supporting stent structure is formed. The vascular filter (20) is laser cut from an intermediate tube (10).
摘要:
A medical product comprises a biodegradable filament and a non-biodegradeable coating. The biodegradable filament forms a stent body having a first end portion, a middle portion, and a second end portion opposite the first end portion. The middle portion extends between the first and second end portions. The non-biodegradeable coating encapsulates the at least one biodegradable filament along the middle portion of the stent body. The non-biodegradeable coating forms a barrier such that the non-biodegradeable coating prevents degradation of the at least one biodegradable filament along the middle portion. The first and second end portions are uncoated. After implantation, the end portions of the stent may biodegrade. The middle portion will not biodegrade due to its encapsulation by the non-biodegradeable coating.